logo

INSM

InsmedยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

INSM Profile

Insmed Incorporated

A biopharmaceutical company focused on developing and commercializing innovative therapies for rare and serious diseases

Pharmaceutical
11/29/1999
06/01/2000
NASDAQ Stock Exchange
1,271
12-31
Common stock
700 US Highway 202/206, Bridgewater, New Jersey 08807
--
Insmed Incorporated is a biopharmaceutical company focused on developing inhaled therapies to combat life-threatening lung diseases for patients. The company's flagship products ARIKACE and amikacin liposome inhalation are an inhaled antibiotic therapy, proving that anti-infectives can improve the efficacy, safety and convenience of the therapy in the treatment of severe lung infections. The company was established in Commonwealth Virginia on November 29, 1999.